Literature DB >> 6585234

Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients.

I D Dubé, D K Kalousek, L Coulombel, C M Gupta, C J Eaves, A C Eaves.   

Abstract

We recently showed that long-term marrow cultures can be used to demonstrate the presence of Philadelphia (Ph1) negative progenitors in patients with newly diagnosed Ph1-positive chronic myeloid leukemia (CML). We now report results for 6 chronic phase patients studied 5-83 mo postdiagnosis and an additional 3 newly diagnosed patients. Marrow metaphases were exclusively Ph1-positive. Clonogenic assays revealed a minor population of Ph1-negative progenitors in 3 cases (1 treated, 2 untreated). Long-term marrow culture adherent layers contained Ph1-negative progenitors in 6 cases (3 treated, 3 untreated). Whenever this occurred, the Ph1-negative population had become the only one detectable within 3-4 wk, and this was always associated with a rapid decline of the Ph1-positive population. For 2 of the 3 cases where Ph1-negative progenitors were not detected, there was a similar rapid decline in the Ph1-positive population in culture. In the other case, Ph1-positive progenitors were maintained at levels typically seen in normal long-term marrow cultures. These results suggest that chromosomally normal stem cells may persist for a considerable period in the marrow of some, but perhaps not all, patients with CML, even in the face of maintenance chemotherapy. In addition, they provide new evidence of heterogeneity in this disease, as shown by the variable ability of Ph1-positive progenitor populations to be maintained in vitro.

Entities:  

Mesh:

Year:  1984        PMID: 6585234

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.

Authors:  G Bazzoni; N Carlesso; J D Griffin; M E Hemler
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha.

Authors:  G Egert; L Kanz; G W Löhr; A A Fauser
Journal:  Blut       Date:  1990-05

3.  Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.

Authors:  Salem Akel; Despina Mavroyanni; Xenophon Yataganas; Evagelos Terpos; John Meletis; Kostas Anargyrou; Niki Stavrogianni; Gerasimos-Alexander Pangalis; Dimitris Loukopoulos; Nora Viniou
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

4.  Pre CFU-F in bone marrow cultures from children with hematopoietic disease including acute leukemia.

Authors:  G Prindull; Z Ben-Ishay; B Prindull
Journal:  Blut       Date:  1987-12

Review 5.  Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects.

Authors:  F Cervantes; C Rozman
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

6.  Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.

Authors:  L Coulombel; C Eaves; D Kalousek; C Gupta; A Eaves
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

7.  Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells.

Authors:  A C Eaves; J D Cashman; L A Gaboury; D K Kalousek; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.

Authors:  C J Eaves; J D Cashman; S D Wolpe; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.

Authors:  M Nolte; M Werner; M Ewig; R von Wasielewski; H Link; H Diedrich; A Georgii
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

10.  Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.

Authors:  G Pasternak; L Pasternak
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.